Happy Holidays from Zelmic – Reflecting on a Year of Growth and Collaboration
December 22, 2025
As 2025 comes to a close, we at Zelmic AB would like to extend our sincere thanks to our clients, collaborators, and partners for a truly remarkable year.
This year has been a period of innovation and transformation in topical and transdermal drug development. Together, we have continued to advance projects that push the boundaries of science, turning complex formulation challenges into practical, patient-focused solutions.
Strengthened by Integration into the CTR Group
One of the most exciting milestones of 2025 was Zelmic’s integration into the CTR Group, alongside CTC Clinical Trial Consultants, Lablytica and Regsmart. This strategic collaboration enables us to offer a complete development pathway, from preclinical formulation and analytical development through regulatory submission and early clinical trials.
With Zelmic’s deep expertise in topical formulations, we now provide our clients with:
• Broader regulatory and clinical support
• Increased project resilience and efficiency
This marks an important step in Zelmic’s evolution, strengthening our role as a full-service partner in topical and transdermal product development.
Looking Ahead to 2026
As we move into 2025, our focus remains clear: to innovate, collaborate, and deliver high-quality topical drug products that make a difference. We look forward to continuing our partnerships with both new and long-standing clients, helping bring more effective and safe topical therapies to patients worldwide.
Thank You for a Wonderful Year
The holiday season is a time to reflect and celebrate achievements. At Zelmic, we’re proud of the progress we’ve made together and excited for what lies ahead.
From all of us at Zelmic, we wish you a Merry Christmas and a Happy New Year!
Warm regards,
The Zelmic Team
